Page last updated: 2024-09-05

tolvaptan and Cirrhosis

tolvaptan has been researched along with Cirrhosis in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (12.50)29.6817
2010's6 (75.00)24.3611
2020's1 (12.50)2.80

Authors

AuthorsStudies
Duan, X; He, Y; Wu, Q; Yan, F; Zhu, H1
Nitta, K; Ogawa, T1
Li, G; Liu, R; Ma, Z; Wang, W; Yuan, M; Zhang, K; Zhang, Y1
Aonuma, K; Chiba, H; Ishizu, T; Namekawa, M; Sai, S; Seo, Y1
Joseph, J; Joseph, L; Zhang, L1
Fujiki, H; Hanatani, A; Iwao, H; Izumi, Y; Miura, K; Nakamura, Y; Osada-Oka, M; Shimada, K; Shiota, M; Yamazaki, T; Yoshiyama, M1
Akahoshi, Y; Fujiki, H; Ikeda, T; Iwanaga, Y; Miyazaki, S; Morooka, H; Watanabe, H1
Greenberg, A; Verbalis, JG1

Reviews

2 review(s) available for tolvaptan and Cirrhosis

ArticleYear
Clinical Impact of Left Ventricular Diastolic Dysfunction in Chronic Kidney Disease.
    Contributions to nephrology, 2018, Volume: 195

    Topics: Adrenergic beta-Antagonists; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antidiuretic Hormone Receptor Antagonists; Antihypertensive Agents; Calcimimetic Agents; Calcium Channel Blockers; Diet, Sodium-Restricted; Diuretics; Echocardiography; Echocardiography, Doppler; Fibrosis; Heart Failure, Diastolic; Histamine Antagonists; Humans; Hypertrophy, Left Ventricular; Myocardium; Renal Dialysis; Renal Insufficiency, Chronic; Sodium-Glucose Transporter 2 Inhibitors; Tolvaptan; Ventricular Dysfunction, Left

2018
Vasopressin receptor antagonists.
    Kidney international, 2006, Volume: 69, Issue:12

    Topics: Antidiuretic Hormone Receptor Antagonists; Azepines; Benzamides; Benzazepines; Clinical Trials as Topic; Diabetes Insipidus, Nephrogenic; Fibrosis; Heart Failure; Humans; Hyponatremia; Osmolar Concentration; Polycystic Kidney Diseases; Pyrroles; Receptors, Vasopressin; Sodium; Tolvaptan; United States; United States Food and Drug Administration; Vasopressins

2006

Other Studies

6 other study(ies) available for tolvaptan and Cirrhosis

ArticleYear
Combination of tolvaptan and valsartan improves cardiac and renal functions in doxorubicin-induced heart failure in mice.
    European journal of histochemistry : EJH, 2022, Nov-11, Volume: 66, Issue:4

    Topics: Animals; bcl-2-Associated X Protein; Caspase 3; Doxorubicin; Fibrosis; Heart Failure; Inflammation; Kidney; Kidney Diseases; Mice; Stroke Volume; Tolvaptan; Valsartan; Ventricular Function, Left

2022
Beneficial effects of tolvaptan on atrial remodeling induced by chronic intermittent hypoxia in rats.
    Cardiovascular therapeutics, 2018, Volume: 36, Issue:6

    Topics: Action Potentials; Animals; Atrial Fibrillation; Atrial Remodeling; Chronic Disease; Collagen; Disease Models, Animal; Fibrosis; Gene Expression Regulation; Heart Atria; Heart Rate; Hypoxia; Intracellular Signaling Peptides and Proteins; Male; Matrix Metalloproteinase 9; MicroRNAs; Rats, Sprague-Dawley; Signal Transduction; Tolvaptan

2018
Renoprotective effects of tolvaptan in hypertensive heart failure rats depend on renal decongestion.
    Hypertension research : official journal of the Japanese Society of Hypertension, 2019, Volume: 42, Issue:3

    Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Central Venous Pressure; Fibrosis; Heart Failure; Hemodynamics; Hypertension; Kidney Diseases; Kidney Medulla; Male; Protective Agents; Rats; Rats, Inbred Dahl; Sodium, Dietary; Stroke Volume; Tolvaptan; Ultrasonography; Vascular Resistance

2019
In Vivo and In Vitro Effects of Vasopressin V2 Receptor Antagonism on Myocardial Fibrosis in Rats.
    The American journal of the medical sciences, 2019, Volume: 357, Issue:2

    Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Cardiomyopathies; Diet; Fibrosis; Heart Failure; Male; Rats; Rats, Sprague-Dawley; Receptors, Vasopressin; Sodium Chloride; Tolvaptan

2019
Tolvaptan attenuates left ventricular fibrosis after acute myocardial infarction in rats.
    Journal of pharmacological sciences, 2013, Sep-20, Volume: 123, Issue:1

    Topics: Acute-Phase Reaction; Animals; Benzazepines; Disease Models, Animal; Drug Therapy, Combination; Fibrosis; Furosemide; Heart Failure; Heart Ventricles; Male; Myocardial Infarction; Rats; Rats, Wistar; Tolvaptan; Ventricular Dysfunction, Left; Ventricular Remodeling

2013
Effects of Long-term Blockade of Vasopressin Receptor Types 1a and 2 on Cardiac and Renal Damage in a Rat Model of Hypertensive Heart Failure.
    Journal of cardiovascular pharmacology, 2015, Volume: 66, Issue:5

    Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Disease Models, Animal; Drug Therapy, Combination; Fibrosis; Gene Expression Regulation; Heart Failure; Heart Ventricles; Hemodynamics; Hypertension; Hypertrophy, Left Ventricular; Kidney; Kidney Diseases; Male; Piperidines; Quinolones; Rats, Inbred Dahl; Receptors, Vasopressin; Time Factors; Tolvaptan; Ventricular Function, Left; Ventricular Remodeling

2015